How much profit has Qiagen made this year?
Qiagen has made 477.43 M USD this year.
Qiagen Net Income 2024
Qiagen Net Income
477.43 M USD
Qiagen Dividend yield
2.38 %
Ticker
QGEN
ISIN
NL0012169213
WKN
A2DKCH
In 2024, Qiagen's profit amounted to 477.43 M USD, a 39.89% increase from the 341.3 M USD profit recorded in the previous year.
The Qiagen Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2028e | 676.82 |
| 2027e | 620.35 |
| 2026e | 572.6 |
| 2025e | 520.95 |
| 2024e | 477.43 |
| 2023 | 341.3 |
| 2022 | 423.2 |
| 2021 | 512.6 |
| 2020 | 359.2 |
| 2019 | -41.5 |
| 2018 | 190.4 |
| 2017 | 40.4 |
| 2016 | 80.4 |
| 2015 | 130.1 |
| 2014 | 116.6 |
| 2013 | 69.1 |
| 2012 | 129.5 |
| 2011 | 96 |
| 2010 | 144.3 |
| 2009 | 137.8 |
| 2008 | 89 |
| 2007 | 50.1 |
| 2006 | 70.5 |
| 2005 | 62.2 |
| 2004 | 48.7 |
Qiagen Aktienanalyse
What does Qiagen do?
Qiagen NV is a biotechnology company based in Venlo, Netherlands. The company was founded in 1984 as a spin-off from the University of Düsseldorf and has since become a leading provider of molecular diagnostic products and systems. Qiagen operates in four business areas: Life Sciences, Molecular Diagnostics, Applied Testing, and Pharma. Life Sciences is the largest business area of the company and offers a wide range of products for DNA sequencing, gene expression, RNA isolation and analysis, as well as protein analysis. Molecular Diagnostics specializes in diagnostic tests for diseases such as cancer, infections, and genetic disorders. Applied Testing provides solutions for forensic analysis and food and environmental analysis, while Pharma offers products and services for drug discovery and development. In recent years, Qiagen has focused mainly on the development of molecular diagnostic tests for cancer and infection-related diseases such as HIV, hepatitis, and tuberculosis. These tests enable earlier detection of diseases and more targeted therapy, improving patient care and reducing healthcare costs. One example of a successful Qiagen product is the Cobas HPV Test, a molecular diagnostic test for the detection of human papillomaviruses (HPV) responsible for cervical cancer. The test is distributed by Roche Diagnostics and is one of the best-selling molecular diagnostic tests in the world. Qiagen also has a strong presence in academic research and is a major provider of tools and technologies for DNA sequencing and genome research. Customers include leading research institutes, universities, and pharmaceutical companies. In recent years, Qiagen has also expanded through acquisitions to expand its offering of products and technologies and enter new markets. For example, in 2018, the company acquired N-of-One, a provider of artificial intelligence in cancer diagnostics, and NeuMoDx Molecular, a provider of molecular diagnostic platforms for laboratories. In 2020, Qiagen also played a crucial role in the development of tests for the new coronavirus (SARS-CoV-2). The company, together with other leading diagnostic companies, developed molecular diagnostic tests for rapid and reliable diagnosis of COVID-19. Overall, Qiagen is an important player in the biotech industry, offering a wide range of products and services for molecular diagnostics, genome research, and pharmaceutical research. Qiagen has a strong competitive position due to its innovative products and technologies, strong presence in academic research, and strategic acquisitions to expand its product portfolio and market access. Qiagen ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Qiagen's Profit Margins
The profit margins of Qiagen represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Qiagen's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Qiagen's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Qiagen's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Qiagen’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Qiagen Stock
How has the profit developed compared to last year?
The profit has increased by 39.89% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Qiagen publish its earnings?
Qiagen publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Qiagen?
The profits of Qiagen are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Qiagen?
You can learn more about the earnings of Qiagen by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Qiagen pay?
Over the past 12 months, Qiagen paid a dividend of 1.08 USD . This corresponds to a dividend yield of about 2.38 %. For the coming 12 months, Qiagen is expected to pay a dividend of 0 USD.
What is the dividend yield of Qiagen?
The current dividend yield of Qiagen is 2.38 %.
When does Qiagen pay dividends?
Qiagen pays a quarterly dividend. This is distributed in the months of February, February, February, February.
How secure is the dividend of Qiagen?
Qiagen paid dividends every year for the past 5 years.
What is the dividend of Qiagen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Qiagen located?
Qiagen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Qiagen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Qiagen from 2/1/2024 amounting to 1.32 USD, you needed to have the stock in your portfolio before the ex-date on 1/30/2024.
When did Qiagen pay the last dividend?
The last dividend was paid out on 2/1/2024.
What was the dividend of Qiagen in the year 2023?
In the year 2023, Qiagen distributed 0 USD as dividends.
In which currency does Qiagen pay out the dividend?
The dividends of Qiagen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Qiagen stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Qiagen
Our stock analysis for Qiagen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Qiagen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.